{"id":"https://openalex.org/W7220917229","doi":"https://doi.org/10.1016/j.htct.2026.108542","title":"Are quality of life data reported in clinical trials evaluating CAR T cells in hematologic malignancies?","display_name":"Are quality of life data reported in clinical trials evaluating CAR T cells in hematologic malignancies?","publication_year":2026,"publication_date":"2026-10-01","ids":{"openalex":"https://openalex.org/W7220917229","doi":"https://doi.org/10.1016/j.htct.2026.108542","pmid":"https://pubmed.ncbi.nlm.nih.gov/42849369","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13675636"},"language":"en","primary_location":{"id":"doi:10.1016/j.htct.2026.108542","doi":"https://doi.org/10.1016/j.htct.2026.108542","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.htct.2026.108542","pdf_url":"https://www.sciencedirect.com/science/article/pii/S2531137926022893/pdf","source":{"id":"https://openalex.org/S2898598332","display_name":"Hematology Transfusion and Cell Therapy","issn_l":"2531-1379","issn":["2531-1379","2531-1387"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","ki-jl-1","poland-20","russia-white-list-3","scielo"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hematology, Transfusion and Cell Therapy","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://www.sciencedirect.com/science/article/pii/S2531137926022893/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5157982886","display_name":"Julie Bouaziz-Bohbot","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I100532134","display_name":"Lyon 1 Universit\u00e9","ror":"https://ror.org/029brtt94","country_code":"FR","type":"education","lineage":["https://openalex.org/I100532134","https://openalex.org/I203339264"]},{"id":"https://openalex.org/I4405260950","display_name":"Centre pour l'innovation en canc\u00e9rologie de Lyon","ror":"https://ror.org/04h6jac11","country_code":"FR","type":"facility","lineage":["https://openalex.org/I100532134","https://openalex.org/I203339264","https://openalex.org/I4405260950"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Julie Bouaziz-Bohbot","raw_affiliation_strings":["Lyon I University, EA 3738 - CICLY, Lyon Sud University, Lyon, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lyon I University, EA 3738 - CICLY, Lyon Sud University, Lyon, France","institution_ids":["https://openalex.org/I100532134","https://openalex.org/I4405260950"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027311948","display_name":"Lionel Karlin","orcid":"https://orcid.org/0000-0002-1185-4488","observed_orcids":["https://orcid.org/0000-0002-1185-4488"]},"institutions":[{"id":"https://openalex.org/I4210100596","display_name":"Hospices Civils de Lyon","ror":"https://ror.org/01502ca60","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210100596"]},{"id":"https://openalex.org/I4210113288","display_name":"H\u00f4pital Lyon Sud","ror":"https://ror.org/023xgd207","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210100596","https://openalex.org/I4210113288"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Lionel Karlin","raw_affiliation_strings":["Hematology Department, Lyon Sud Hospital, Hospices Civils de Lyon, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology Department, Lyon Sud Hospital, Hospices Civils de Lyon, France","institution_ids":["https://openalex.org/I4210100596","https://openalex.org/I4210113288"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086354986","display_name":"Gilles Andre Salles","orcid":"https://orcid.org/0000-0002-9541-8666","observed_orcids":["https://orcid.org/0000-0002-9541-8666"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gilles A. Salles","raw_affiliation_strings":["Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, NY, United States"],"raw_orcid":"https://orcid.org/0000-0002-9541-8666","affiliations":[{"raw_affiliation_string":"Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, NY, United States","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5046006290","display_name":"Catherine Rioufol","orcid":"https://orcid.org/0000-0002-9728-8092","observed_orcids":["https://orcid.org/0000-0002-9728-8092"]},"institutions":[{"id":"https://openalex.org/I100532134","display_name":"Lyon 1 Universit\u00e9","ror":"https://ror.org/029brtt94","country_code":"FR","type":"education","lineage":["https://openalex.org/I100532134","https://openalex.org/I203339264"]},{"id":"https://openalex.org/I4210100596","display_name":"Hospices Civils de Lyon","ror":"https://ror.org/01502ca60","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210100596"]},{"id":"https://openalex.org/I4210113288","display_name":"H\u00f4pital Lyon Sud","ror":"https://ror.org/023xgd207","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210100596","https://openalex.org/I4210113288"]},{"id":"https://openalex.org/I4405260950","display_name":"Centre pour l'innovation en canc\u00e9rologie de Lyon","ror":"https://ror.org/04h6jac11","country_code":"FR","type":"facility","lineage":["https://openalex.org/I100532134","https://openalex.org/I203339264","https://openalex.org/I4405260950"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Catherine Rioufol","raw_affiliation_strings":["Lyon I University, EA 3738 - CICLY, Lyon Sud University, Lyon, France; Clinical Oncology Pharmacy Unit, Lyon Sud Hospital, Hospices Civils de Lyon, France. Electronic address: catherine.rioufol@chu-lyon.fr"],"raw_orcid":"https://orcid.org/0000-0002-9728-8092","affiliations":[{"raw_affiliation_string":"Lyon I University, EA 3738 - CICLY, Lyon Sud University, Lyon, France; Clinical Oncology Pharmacy Unit, Lyon Sud Hospital, Hospices Civils de Lyon, France. Electronic address: catherine.rioufol@chu-lyon.fr","institution_ids":["https://openalex.org/I100532134","https://openalex.org/I4210100596","https://openalex.org/I4210113288","https://openalex.org/I4405260950"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5046006290"],"corresponding_institution_ids":["https://openalex.org/I100532134","https://openalex.org/I4210100596","https://openalex.org/I4210113288","https://openalex.org/I4405260950"],"apc_list":{"value":0,"currency":"USD","value_usd":0},"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.73039185,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"48","issue":"4","first_page":"108542","last_page":"108542"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.9312000274658203,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.9312000274658203,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.016599999740719795,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10178","display_name":"Cancer survivorship and care","score":0.014700000174343586,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/car-t-cell-therapy","display_name":"CAR T-cell therapy","score":0.9909999966621399},{"id":"https://openalex.org/keywords/health-related-quality-of-life","display_name":"health-related quality of life","score":0.9940000176429749},{"id":"https://openalex.org/keywords/clinical-trial-endpoints","display_name":"clinical trial endpoints","score":0.7179999947547913},{"id":"https://openalex.org/keywords/patient-reported-outcomes","display_name":"patient-reported outcomes","score":0.6909999847412109},{"id":"https://openalex.org/keywords/hematologic-malignancies","display_name":"hematologic malignancies","score":0.8180000185966492},{"id":"https://openalex.org/keywords/lymphoma","display_name":"lymphoma","score":0.8330000042915344},{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":0.9940000176429749},{"id":"https://openalex.org/keywords/leukemia","display_name":"leukemia","score":0.9980000257492065},{"id":"https://openalex.org/keywords/outcome-standardization","display_name":"outcome standardization","score":0.7250000238418579},{"id":"https://openalex.org/keywords/clinicaltrials-gov","display_name":"ClinicalTrials.gov","score":0.7670000195503235}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9524000287055969},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.7530999779701233},{"id":"https://openalex.org/C2779951463","wikidata":"https://www.wikidata.org/wiki/Q7268788","display_name":"Quality of life (healthcare)","level":2,"score":0.5947999954223633},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.4869000017642975},{"id":"https://openalex.org/C2779530757","wikidata":"https://www.wikidata.org/wiki/Q1207505","display_name":"Quality (philosophy)","level":2,"score":0.4106999933719635},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.34549999237060547},{"id":"https://openalex.org/C3018822202","wikidata":"https://www.wikidata.org/wiki/Q1324077","display_name":"Patient data","level":2,"score":0.3310000002384186},{"id":"https://openalex.org/C194828623","wikidata":"https://www.wikidata.org/wiki/Q2861470","display_name":"Emergency medicine","level":1,"score":0.31369999051094055},{"id":"https://openalex.org/C24756922","wikidata":"https://www.wikidata.org/wiki/Q1757694","display_name":"Data quality","level":3,"score":0.28780001401901245},{"id":"https://openalex.org/C2911194787","wikidata":"https://www.wikidata.org/wiki/Q5099363","display_name":"CAR T-cell therapy","level":5,"score":0.28540000319480896}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.1016/j.htct.2026.108542","doi":"https://doi.org/10.1016/j.htct.2026.108542","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.htct.2026.108542","pdf_url":"https://www.sciencedirect.com/science/article/pii/S2531137926022893/pdf","source":{"id":"https://openalex.org/S2898598332","display_name":"Hematology Transfusion and Cell Therapy","issn_l":"2531-1379","issn":["2531-1379","2531-1387"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","ki-jl-1","poland-20","russia-white-list-3","scielo"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hematology, Transfusion and Cell Therapy","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13675636","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13675636/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13675636/pdf/main.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hematol Transfus Cell Ther","raw_type":"Text"},{"id":"pmid:42849369","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42849369","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hematology, transfusion and cell therapy","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:6143ccd5ee684a21934576cb723e3fe6","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/6143ccd5ee684a21934576cb723e3fe6","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Hematology, Transfusion and Cell Therapy, Vol 48, Iss 4, Pp 108542- (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1016/j.htct.2026.108542","doi":"https://doi.org/10.1016/j.htct.2026.108542","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.htct.2026.108542","pdf_url":"https://www.sciencedirect.com/science/article/pii/S2531137926022893/pdf","source":{"id":"https://openalex.org/S2898598332","display_name":"Hematology Transfusion and Cell Therapy","issn_l":"2531-1379","issn":["2531-1379","2531-1387"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","ki-jl-1","poland-20","russia-white-list-3","scielo"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hematology, Transfusion and Cell Therapy","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7220917229.pdf","grobid_xml":"https://content.openalex.org/works/W7220917229.grobid-xml"},"referenced_works_count":30,"referenced_works":["https://openalex.org/W2015368967","https://openalex.org/W2046807069","https://openalex.org/W2053681040","https://openalex.org/W2090247445","https://openalex.org/W2113750014","https://openalex.org/W2145947267","https://openalex.org/W2162420979","https://openalex.org/W2167571044","https://openalex.org/W2168448906","https://openalex.org/W2557509605","https://openalex.org/W2773804840","https://openalex.org/W2787301955","https://openalex.org/W2902598369","https://openalex.org/W2911955223","https://openalex.org/W2975222174","https://openalex.org/W2979947027","https://openalex.org/W3007507981","https://openalex.org/W3133898608","https://openalex.org/W3153061267","https://openalex.org/W3154903133","https://openalex.org/W3157319952","https://openalex.org/W3188949397","https://openalex.org/W3197920680","https://openalex.org/W3201013983","https://openalex.org/W4285492548","https://openalex.org/W4297016769","https://openalex.org/W4303473194","https://openalex.org/W4310593501","https://openalex.org/W4319059258","https://openalex.org/W4387396510"],"related_works":["https://openalex.org/W3197920680","https://openalex.org/W4392556007","https://openalex.org/W3092454488","https://openalex.org/W4405749862","https://openalex.org/W3030565042","https://openalex.org/W4220921096","https://openalex.org/W2979910156","https://openalex.org/W3112508633","https://openalex.org/W2949484690","https://openalex.org/W7165355703"],"abstract_inverted_index":{"BACKGROUND:":[0],"Increasing":[1],"indications":[2],"for":[3,52,74,185],"CAR":[4,53,204],"T":[5],"cells":[6],"in":[7,25,46,56,154,197],"early-line":[8],"hematological":[9,57],"malignancies":[10],"underscore":[11],"the":[12,36,64,83,124],"need":[13],"to":[14,34,78,193],"report":[15],"patient":[16,21],"experiences.":[17],"However,":[18],"data":[19,100,167,196],"regarding":[20,101],"quality":[22],"of":[23,38,41,63,68,118,146,157,162,189],"life":[24],"this":[26],"setting":[27],"remain":[28],"limited.":[29],"OBJECTIVE:":[30],"This":[31],"study":[32,102],"aimed":[33],"assess":[35],"inclusion":[37,125],"Health-Related":[39,144,187],"Quality":[40,145,188],"Life":[42,147,190],"as":[43,150],"an":[44],"endpoint":[45,140,153],"clinical":[47,198],"trials":[48,75,122,199],"registered":[49,76],"on":[50],"ClinicalTrials.gov":[51],"T-cell":[54,205],"therapies":[55],"malignancies.":[58],"METHODS:":[59],"A":[60,159],"comprehensive":[61],"search":[62],"U.S.":[65],"National":[66],"Institutes":[67],"Health":[69],"database":[70],"(ClinicalTrials.gov)":[71],"was":[72,141,148],"performed":[73],"up":[77],"August":[79],"28,":[80],"2022,":[81],"using":[82],"keywords":[84],"\"CAR\"":[85],"AND":[86],"(\"lymphoma\"":[87],"OR":[88,91,93],"\"multiple":[89],"myeloma\"":[90],"\"leukemia\"":[92],"\"hematologic":[94],"malignancy\").":[95],"For":[96],"each":[97],"selected":[98],"trial,":[99],"design,":[103],"setting,":[104],"indication,":[105],"treatment":[106],"line,":[107],"relevant":[108],"outcomes,":[109],"and":[110,127,166,173,200],"evaluation":[111],"scales":[112],"were":[113,128,164],"collected.":[114],"MAIN":[115],"RESULTS:":[116],"Out":[117],"1281":[119],"records,":[120],"429":[121],"met":[123],"criteria":[126],"analyzed,":[129],"with":[130],"over":[131],"half":[132],"being":[133],"phase":[134],"1.":[135],"The":[136],"most":[137],"common":[138],"primary":[139],"safety":[142],"(47%).":[143],"assessed":[149],"a":[151,182],"secondary":[152],"only":[155],"11%":[156],"trials.":[158],"wide":[160],"variety":[161],"questionnaires":[163],"identified,":[165],"collection":[168],"methodologies":[169],"(baseline":[170],"assessments,":[171],"timepoints,":[172],"follow-up":[174],"duration)":[175],"varied":[176],"considerably":[177],"across":[178],"studies.":[179],"CONCLUSION:":[180],"Establishing":[181],"standardized":[183],"consensus":[184],"measuring":[186],"is":[191],"essential":[192],"complement":[194],"efficacy":[195],"real-world":[201],"studies":[202],"evaluating":[203],"therapies.":[206]},"counts_by_year":[],"updated_date":"2026-11-08T12:12:28.789561","created_date":"2026-10-09T00:00:00"}